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PURPOSE: To evaluate distance and near image quality after hybrid bi-aspheric 
multifocal central presbyLASIK treatments. 
 
DESIGN: Consecutive case series 
 
Methods: Sixty-four eyes of 32 patients  consecutively treated with central presbyLASIK 
were assessed. The mean age of the patients was 51±3 years with a mean spherical 
equivalent refraction of -1.08±2.62D and mean astigmatism of 0.52±0.42D. Monocular 
corrected distance visual acuity (CDVA), corrected near visual acuity (CNVA) and 
distance corrected near visual acuity (DCNVA) of non-dominant eyes; binocular 
uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity 
(UIVA), distance corrected intermediate visual acuity (DCIVA) and uncorrected near 
visual acuity (UNVA) were assessed pre- and post-operatively. Subjective quality of 
vision and near vision was assessed using the 10-item, Rasch-scaled, Quality of Vision  
and Near Activity Visual Questionnaire  respectively. 
  
RESULTS: At one year post-operatively, 93% of patients achieved 20/20 or better 
binocular UDVA; 90% and 97% of patients had J2 or better UNVA and UIVA 
respectively; 7% lost 2 Snellen lines of CDVA; Strehl ratio reduced by ~-4±14%. 
Defocus curves revealed a loss of half a Snellen line at best focus, with no change for 
intermediate vergence (-1.25D) and a mean gain of 2 lines for near vergence (-3D). 
  
CONCLUSIONS: Presbyopic treatment using a hybrid bi-aspheric micro-monovision 
ablation profile is safe and efficacious. The post-operative outcomes indicate 
improvements in binocular vision at far, intermediate and near distances with improved 
contrast sensitivity. A 19% retreatment rate should be considered to increase 
satisfaction levels, besides a 3% reversal rate. 
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Introduction 
 
Presbyopia is an age related condition characterized by the gradual loss of the eye’s 
ability to focus actively on nearby objects. This condition is mainly attributed to a loss of 
elasticity of the crystalline lens, accompanied by a change in the ciliary muscle strength 
and lens curvature1. Refractive surgeons have faced challenges in effectively combining 
the treatment of refractive errors and presbyopia. Surgical presbyopia corrections have 
seen several developments from the monovision and multifocal ablation techniques, to 
the modern hybrid methods combining the benefits of several techniques. Corneal 
inlays and intraocular lenses have also been a popular alternative treatment for 
presbyopia2. Monovision techniques3 usually involve correcting the dominant eye for 
distance as opposed to crossed monovision4 where the dominant eye is corrected for 
near vision.  
Charman5 proposed that the main aim of presbyopia treatments was to extend 
the binocular depth-of-focus to yield adequate distance- and near vision with good 
retinal contrast at lower spatial frequencies. Dai6 first proposed the use of rigorous 
methodologies to theoretically optimize vision over the entire target range from near to 
distance. Multifocal ablations are designed to achieve these characteristics. These 
result in a pseudo-accommodative cornea realized in the form of either a peripheral 
near zone (concentric ring for near vision)7 or in the form of a central near zone (central 
disc for near vision)8.   
PresbyLASIK is one such robust technique based on traditional Laser-Assisted in 
situ Keratomileusis (LASIK) to correct the visual defect for distance while 
simultaneously reducing the near spectacle dependency in presbyopic patients9,10.  
PresbyLASIK  has been stated as a promising technology, but lacking the level of 
maturity of monovision11. For achieving maximum patient satisfaction, good near vision 
should be accompanied with no detrimental effect in the distance vision. A hybrid 
method combining micro-monovision and multifocal ablation could potentially achieve 
full range of vision.  
In this work, a Hybrid bi-aspheric micro-monovision technique is presented and 
the outcomes are retrospectively analyzed in 64 consecutive eyes (of 32 patients) 
treated using this method.   
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METHODS 
 
PATIENTS 
 
This cohort study was based on a consecutive case series of patients treated by a 
single surgeon (MHAL), with the hybrid bi-aspheric micro-monovision technique to 
correct presbyopia, at VisionClinics, Utrecht, the Netherlands. Proper informed consent 
was obtained from each patient, for both the treatment and use of their de-identified 
clinical data for publication. The Independent Review Board Nijmegen (IRBN) evaluated 
the study and stated that the investigation in this form is not subject to Medical 
Research Involving Human Subjects Act (WMO). The outcomes of performing 
presbyLASIK in 64 consecutive eyes (32 patients) were retrospectively analyzed. The 
average age of the 32 patients (17 male and 15 female; 17 Hyperopes and 15 Myopes) 
was 51±3 years (range 45 to 55 years). The mean preoperative spherical equivalent 
was -1.08±2.62D (-6.75 to 2.00D), with mean preoperative astigmatism 0.54 ± 0.50 D 
(0.00 to 2.10 D), and mean spectacle near addition 1.75 ± 0.36 D (1.00 to 2.50 D).  
To categorize the candidate as presbyopic, the monocular corrected near visual 
acuity (CNVA) at 40cm had to be at least two logRAD lines better than the distance 
corrected near visual acuity (DCNVA) at 40cm in each eye. Inclusion criteria were 
patients older than 45 years, medically suitable for LASIK, presbyopic with corrected 
distance visual acuity (CDVA) no worse than 20/32 in either eye (with at least 20/25 in 
the best eye), stable refraction (<0.5D change in mean spherical equivalent) for 1 year 
prior to the study,  discontinued usage of contact lenses for at least 2 to 4 weeks 
(depending on contact lens type) prior to the- preoperative evaluation and photopic pupil 
diameter smaller than 3.0 mm. The pupil diameters were obtained from the topographic 
measurements. Patients were required to have normal keratometry and topography 
(visually no suspect or form fruste keratoconus).  Patients who suffered from systemic 
illness, had a calculated corneal bed thickness less than 300µm after ablation, had 
preoperative central corneal thickness of less than 470µm, had previous ocular surgery 
or had abnormal corneal topography were excluded from the study.  Additional 
exclusion criteria were clinically-relevant lens opacity, a pupil offset of 0.7mm or more 
and any signs of binocular vision anomalies at distance and near. 
 
PREOPERATIVE ASSESSMENT 
 
A full ophthalmologic examination was performed on all the patients prior to surgery 
including manifest refraction, cycloplegic refraction, slit-lamp microscopy of the anterior 
segment, handheld ultrasound pachymetry (Corneo-Gage Plus; Sonogage, Cleveland, 
Ohio), dilated funduscopy, and Goldmann intraocular pressure measurement. CDVA 
and uncorrected distance visual acuity (UDVA) were assessed with 
Early Treatment Diabetic Retinopathy Study (ETDRS) charts. Near and intermediate 
acuity was assessed unaided and distance corrected (Uncorrected near visual acuity 
(UNVA), DCNVA, uncorrected intermediate visual acuity (UIVA) and distance corrected 
intermediate visual acuity (DCIVA)), with the Dutch version of the Radner Reading 
Charts at 40cm. All the tests were performed binocularly. The selection of the distance 
and near eye was based on a protocol described by Durrie et al12. 
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The corrected visual acuity was always assessed with trial frames and not 
contact lenses. Binocular defocus curves were measured (with both eyes corrected for 
distance, i.e. eliminating the effect of the micro-monovision component) with induced 
lens blur from +1.5D to -4.0D in 0.5D randomized spherical steps, using distance 
ETDRS charts with the letters randomized between presentations and magnification 
effects being accounted for13. 
Contrast sensitivity with and without glare, was measured using the Contrast 
Glare Tester CGT-1000 (Takagi Seiko Co Ltd, Nagano-Ken, Japan) at six target sizes 
(6.3°, 4.0°, 2.5°, 1.6°, 1.0°, and 0.7°) after correcting the refractive error with spectacles.  
Log values of the contrast sensitivity scores were used for statistical analysis. 
Corneal and ocular aberrometry was performed with the OPD Scan II (Nidek, Gamagori, 
Japan) over a 6mm diameter. Root mean square (RMS) higher order aberrations, Strehl 
ratio and corneal asphericity were extracted.  
Subjective, patient reported outcomes were assessed using two questionnaires: 
the Quality of Vision questionnaire and the Near Activity Visual Questionnaire. The 
Quality of Vision questionnaire was developed by McAlinden et al.14,15 to assess 
symptoms such as glare, halos, starbursts etc. with the use of simulation photographs. 
Symptoms are scored based on their frequency, severity and bothersome. The 
questionnaire is valid for use with spectacle wearers, contact lens wearers, and those 
having had laser refractive surgery, intraocular refractive surgery, or eye disease 
including cataract16,17,18. The Near Activity Visual Questionnaire was used to assess 
patient satisfaction with near functional vision19. For both questionnaires the raw 
response scores were converted to a 0-100 Rasch scale with higher scores indicating 
worse quality of vision.     
The Quality of Vision and Near Activity Visual Questionnaire were administered 
preoperatively, and at 3 months, 6 months and one-year postoperatively. Patients were 
instructed to answer the questionnaires at each follow-up visit to account their 
subjective impression in unaided bright and dim lighting conditions. 
 
SURGICAL PROCEDURE 
 
All the treatments were prepared using the SCHWIND PresbyMAX treatment planning 
module in aspheric mode (SCHWIND eye-tech-solutions GmbH and Co. KG, 
Kleinostheim, Germany). The devices used in this study bear the standards of 
European conformity (Conformité Européene or CE marking) but are not approved by 
the U.S. Food and Drug Administration (FDA). The hybrid surgical technique involved 
treating the dominant eye (also referred to as the distant eye) more towards distance 
vision (target refraction -0.1D) and the non-dominant eye (also referred to as the near 
eye) slightly towards near vision (target refraction -0.9 D) for achieving micro-
monovision. Multifocality20,21,22,11 increases the range of intermediate vision with a 
different depth of focus between the distant eye (+1.1D) and the near eye (+2.2D).  
For each treatment, the planning software calculated the size of the optimal 
transition zone, depending on the preoperative refraction and optical treatment zone. 
Drops of topical anaesthetic were instilled in the upper and lower fornices. Flaps were 
made using Intralase iFS 150 KHz femtosecond laser (AMO, Chicago, Illinois, USA) 
with a 100 µm nominal flap thickness. 
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Additional drops of topical anaesthetics were instilled; the lid margins and 
periocular region were disinfected using diluted povidone. A sterile drape covering eye 
lashes and face was used to isolate the surgical field. A lid speculum was inserted to 
allow maximum exposure of the globe. 
Proper alignment of the eye with the laser was achieved with a 1050 Hz infrared 
eye tracker with simultaneous limbus, pupil, and torsion tracking integrated into the 
laser system and centered on the corneal vertex. The eye tracker had a typical 
response time of 1.7 milliseconds with a system total latency time of 2.9 milliseconds. 
The flap was lifted and the excimer laser ablation was delivered to the stroma. Aspheric 
non-wavefront-guided treatments were performed. The ablation profile was centered on 
the corneal vertex determined by the topographer (taking 70% of the pupil offset value), 
which closely approximates the visual axis23,24. Further, the topographic keratometry 
readings at 3mm diameter were used for the compensation of the loss of efficiency 
when ablating the cornea at non-normal incidences.  Patients were requested to look at 
a pulsing green fixation light throughout the ablation.  
The flap was repositioned and the interface was irrigated with balanced salt 
solution, for removing any debris. Patients received topical antibiotic drops QID for 1 
week; corticosteroid drops QID tapering off in 1 week and ocular lubricants as needed. 
 
POSTOPERATIVE EVALUATION 
 
Patients were reviewed at six weeks, three months, six months, and one year post 
operatively. All postoperative follow-up visits included measurement of monocular and 
binocular UDVA, UNVA, UIVA, manifest refraction, CDVA, DCNVA, DCIVA and defocus 
curves. The response to Quality of Vision and Near Activity Visual Questionnaire, 
topography and aberrometery, and contrast sensitivity was recorded at every follow up 
visit except 6-weeks post operatively.  
 
STATISTICAL ANALYSIS 
 
Data were assessed for normality using the Shapiro-Wilk test. Analysis of variance and 
t-tests were performed on normally distributed data and Friedman tests and post-hoc 
Wilcoxon signed-ranks tests when the data was not normally distributed. 
Distance visual acuity was evaluated in logMAR but converted to equivalent 
Snellen fractions for reporting comparability. Similarly, near visual acuity was evaluated 
in logRAD but converted to Jaeger scale for reporting comparability. Manifest refraction 
was used for pre to postoperative comparison. Uncorrected and corrected visual acuity, 
contrast sensitivity, spherical equivalent refraction and refractive astigmatism were 
individually analyzed for myopes and hyperopes.  
 
  
 RESUL
 
The me
6.5mm)
 
EFFICA
 
The dis
year fol
better b
Jaeger 
achieve
Fig. 1. Ch
aspheric 
presente
myopic p
94% hyp
achieved
94% hyp
achieved
patients a
TS 
an optical 
. The total
CY 
tribution of
low up, 93
inocular U
level J2 or
d Jaeger l
anges in bin
micro-mono
d in the left p
atients achie
eropic patien
 Jaeger leve
eropic patien
 Jaeger leve
chieved Jae
treatment 
 ablation z
 binocular 
% myopic 
DVA; 100%
 better UIV
evel J2 or 
ocular unco
vision ablatio
anel and hy
ved 20/20 o
ts achieved 
l J2 or better
ts achieved 
l J2 or better
ger level J2 
zone diam
one range
UDVA, UI
patients an
 myopic p
A; while 9
better UNV
rrected visua
n profile for 
peropic patie
r better binoc
20/20 or bet
 binocular un
Jaeger level
 uncorrected
or better UN
7 
eter was 6
d from 6.8
VA and UN
d 94% hy
atients an
3% myopic
A.   
l acuity at o
presbyopic c
nts are pres
ular uncorre
ter binocular
corrected in
 J2 or better 
 near visual 
VA. 
.58±0.26m
mm to 8.9m
VA are pr
peropic pa
d 94% hyp
 patients a
ne year follow
orneal treatm
ented in the 
cted distanc
 UDVA. Midd
termediate v
UIVA. Botto
acuity (UNV
m (6.0 to 
m. 
esented in
tients achi
eropic pat
nd 88% h
 up after tre
ents. Myop
right panel. T
e visual acu
le left) 100%
isual acuity 
m left) 93 % 
A). Bottom r
7.0mm, me
 figure 1. A
eved 20/20
ients achie
yperopic p
 
ating with H
ic patients a
op left) 93%
ity (UDVA). T
 myopic pat
(UIVA). Midd
myopic patie
ight) 88 % hy
dian 
t one 
 or 
ved 
atients 
ybrid bi-
re 
 of the 
op right) 
ients 
le right) 
nts 
peropic 
 C
disabilit
scores 
without 
at all siz
Fig. 2. Co
treating w
contrast 
represen
remained
but impro
and lowe
postoper
hanges in
y glare (Fi
remained s
the disabi
es). 
ntrast sensi
ith Hybrid b
sensitivity sc
t months and
 similar to th
ved respect
r 95% confid
atively. 
 contrast s
gure 2).  A
imilar to th
lity glare), 
tivity scores 
i-aspheric m
ores were as
 years respe
e respective
ively at 1 yea
ence limits o
ensitivity s
t the 3 and
e respect
but improv
assessed pr
icro-monovis
sessed with
ctively. At 3
 preoperative
r follow up (
f the mean o
8 
cores wer
 6 months
ive preope
ed respect
eoperatively
ion ablation 
 (Top) and w
 and 6 month
 scores in b
p <0.005 at a
f measurem
e assesse
 follow up,
rative scor
ively at the
, 3 months, 6
profile for pr
ithout (Botto
s follow up, 
oth tests (wi
ll sizes). Th
ents, preope
d with and
 the contra
es in both 
 1 year fo
 months and
esbyopic cor
m) disability 
the contrast
th and witho
e error bars 
ratively and 
 without th
st sensitiv
tests (with
llow up (p 
 
 one year af
neal treatme
glare. Here 
 sensitivity sc
ut the disabil
represent the
one year 
e 
ity 
 and 
<0.005 
ter 
nts. The 
M and Y 
ores 
ity glare), 
 upper 
 SAFET
 
The cha
up, 85%
better b
achieve
binocula
patients
 
 
Fig. 3. Ch
Hybrid bi
are prese
year follo
intermed
Jaeger le
achieved
right) At o
DCNVA. 
 
Y 
nge in bin
 myopic p
inocular D
d a Jaege
r CDVA (f
, at one ye
anges in bin
-aspheric mi
nted in the l
w up, 85% m
iate visual ac
vel J2 or bet
 a Jaeger lev
ne year follo
ocular DC
atients and
CIVA; whi
r level J4 o
igure 4) w
ar follow u
ocular dista
cro-monovis
eft panel and
yopic patien
uity (DCIVA
ter binocula
el J4 or bett
w up, 63% h
IVA and D
 94% hyp
le 57% my
r better bi
as observe
p.  
nce correcte
ion ablation 
 hyperopic p
ts achieved 
).  Top right)
r DCIVA.  Bo
er binocular 
yperopic pa
9 
CNVA is p
eropic pat
opic patien
nocular DC
d in 7% m
d visual acui
profile for pre
atients are p
a Jaeger lev
 At one year 
ttom left) At 
distance cor
tients achiev
resented i
ients achie
ts and 63%
NVA. A lo
yopic patie
ty at one yea
sbyopic cor
resented in 
el J2 or bett
follow up, 94
one year foll
rected near v
ed a Jaeger
n figure 3. 
ved a Jaeg
 hyperop
ss of 2 Sn
nts and 6
r follow up a
neal treatme
the right pan
er binocular 
% hyperopic
ow up, 57% 
isual acuity 
 level J4 or b
At one yea
er level J2
ic patients
ellen lines 
% hyperop
fter treating 
nts. Myopic p
el. Top left) 
distance corr
 patients ac
myopic patie
(DCNVA). B
etter binocu
r follow 
 or 
 
of 
ic 
 
with 
atients 
At one 
ected 
hieved a 
nts 
ottom 
lar 
  
Fig. 4. Ch
with Hyb
patients: 
Bottom) 
one year
anges in bin
rid bi-aspher
A loss of 2 S
Hyperopic pa
 follow up. 
ocular corre
ic micro-mon
nellen lines 
tients: A los
cted distanc
ovision abla
of CDVA wa
s of 2 Snelle
10 
e visual acui
tion profile fo
s observed i
n lines of CD
ty (CDVA) at
r presbyopic
n 7% myopic
VA was obs
 one year fo
 corneal trea
 patients at 
erved in 6% 
llow up after 
tments. Top
one year foll
hyperopic pa
 
treating 
) Myopic 
ow up. 
tients at 
 ACCUR
 
For Myo
domina
refractio
within 0
target (-
while 59
patients
hyperop
astigma
domina
(figure 6
betwee
(Figure 
 
 
Fig. 5. Sp
aspheric 
distance 
are prese
patients, 
micro-mo
emmetro
operative
were with
eyes wer
ACY 
pic and hy
nt and non
n and ast
.5D of em
0.9D); in h
% near ey
, 100% dis
ic patients
tism. Refr
nt eye (NE
). A nearly
n the laser
7). 
herical equi
micro-mono
and near eye
nted in the r
100% distan
novision targ
pia while 59%
 refractive a
in 0.5D of a
e within 0.5D
peropic p
-dominant
igmatism (
metropia w
yperopic p
es were w
tance eye
, 100% dis
active stab
) in myopi
 linear (co
 attempted
valent refrac
vision ablatio
 respectivel
ight panel. T
ce eyes wer
et (-0.9D). T
 near eyes 
stigmatism. B
stigmatism. B
 of astigmat
atients, a g
 eye, for re
figure 5). I
hile 67% n
atients, 76
ithin 0.6D
s and 73%
tance eye
ility was a
c and hype
efficient o
 and achie
tion and refra
n profile for 
y. Myopic pa
op) Post-ope
e within 0.5D
op right) In 
were within 
ottom left) I
ottom Right
ism. 
11 
ood separ
fractive de
n myopic p
ear eyes w
% distanc
 of micro-m
 near eyes
s and 59%
chieved fo
ropic patie
f determina
ved spher
ctive astigm
presbyopic c
tients are pr
rative spher
 of emmetro
hyperopic pa
0.6D of micr
n myopic pa
) In hyperop
ation was 
viation fro
atients, 10
ere within
e eyes we
onovision
 were with
 near eye
r both dom
nts, from 
tion r2 = 0
ical equiva
atism one ye
orneal treatm
esented in th
ical equivale
pia while 67
tients, 76%
o-monovision
tients, 100%
ic patients, 1
observed 
m target s
0% distan
 0.6D of m
re within 0
 target (-0.
in 0.5D of
s were with
inant (DE)
6 weeks po
.97, p<.00
lent refrac
ar after trea
ents. Here 
e left panel 
nt refraction
% near eyes
distance eye
 target (-0.9
 distance eye
00% distanc
between th
pherical eq
ce eyes w
icro-mono
.5D of emm
9D).  For m
 astigmatis
in 0.5D of
 and non-
stoperativ
001) relati
tion was o
ting with Hyb
DE and NE r
and hyperop
. Top left) In 
 were within 
s were within
D). Bottom) 
s and 73% 
e eyes and 5
e 
uivalent 
ere 
vision 
etropia 
yopic 
m; in 
 
ely 
onship 
bserved 
 
rid bi-
epresent 
ic patients 
myopic 
0.6D of 
 0.5D of 
Post-
near eyes 
9% near 
  
Fig. 6. M
treating w
Myopic p
respectiv
hyperopi
  
ean spherica
ith Hybrid b
atients.  Bott
ely. Refractiv
c patients, fro
l equivalent 
i-aspheric m
om) Hypero
e stability w
m 6 weeks 
refraction as
icro-monovis
pic patients.
as achieved
postoperativ
12 
sessed preo
ion ablation 
Here W, M a
 for both dist
ely. 
peratively, a
profile for pr
nd Y repres
ance (DE) an
nd at one ye
esbyopic cor
ent weeks, m
d near eye 
 
ar follow up 
neal treatme
onths and y
(NE) in myop
after 
nts. Top) 
ears 
ic and 
13 
 
 
Fig. 7. The relationship between laser setting spherical equivalent refraction and the achieved spherical 
equivalent refraction one year after treating with Hybrid bi-aspheric micro-monovision ablation profile for 
presbyopic corneal treatments. A linear trend can be observed between the attempted and achieved 
refraction in our cohort (R2=0.9754).  
 
 
SUBJECTIVE RATING 
 
Quality of Vision scores assessing symptoms based on their frequency, severity and 
bothersome, are presented in figure 8. Compared to the corrected pre-operative scores, 
the Quality of Vision worsened postoperatively (p = 0.02) mainly with an increase in 
patients seeing haloes (p = 0.002), blurred vision (p = 0.02) and double vision (p = 
0.01).  
Near Activity Visual Questionnaire (NAVQ) scores assessing patient satisfaction 
with near functional vision and overall satisfaction, are presented in figure 9. The Near 
Activity Visual Questionnaire scores improved from little to very high satisfaction level (p 
< 0.00001), with an improvement in Rasch scores (p < 0.0001). Stability was observed 
in Near Activity Visual Questionnaire scores from 3 months follow up time.  
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Fig. 8. Quality of Vision (QoV) questionnaire scores assessing symptoms based on their frequency, 
severity and bothersome, on each follow up visit after presbyLASIK treatment. The raw response scores 
were converted to a 0-100 Rasch scale with higher scores indicating worse quality of vision. A minor 
decline is observed in the Rasch scores post-operatively compared to the corrected pre-operative scores. 
Here M and Y represent months and years respectively. 
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Fig. 9. Near Activity Visual Questionnaire (NAVQ) scores assessing patient satisfaction with near 
functional vision and overall satisfaction level, preoperatively and at the last post-operative visit after 
treating with Hybrid bi-aspheric micro-monovision ablation profile for presbyopic corneal treatments.. The 
raw response scores were converted to a 0-100 Rasch scale with higher scores indicating worse quality 
of vision.NAVQ improved from little to very high satisfaction level, with an improvement in Rasch scores. 
Here ‘Last’ represents the Rasch scores at the last follow up (at 6 months or 1 year postoperatively).  
 
ABERRATIONS 
 
Change in corneal asphericity (Q value) at 3mm diameter, Strehl ratio, Root mean 
square (RMS) of higher order aberrations (at 6mm diameter), corneal and ocular 
spherical aberrations, are presented in figure 10. Asphericity was more prolate after 
surgery indicating a central myopia (within 3mm diameter, p < 0.00001). Compared to 
the preoperative status, one year post-operatively the Strehl ratio reduced by ~-4 ± 14% 
(p = 0.00007), the corneal and ocular spherical aberrations (at 6 mm diameter) 
decreased by -0.38 ± 0.33 µm and -0.28 ± 0.35 µm respectively (p < 0.00001), with an 
increase in RMS higher order aberrations (at 6 mm diameter) by 0.15 ± 0.24 µm (p = 
0.00002). All these metrics indicated good stability from 3 months onwards.  
Binocular defocus curves and the change between defocus curves 
(preoperatively and at 1 year follow up) are presented in figures 11 and 12 respectively. 
Defocus curves indicate stability from 6 weeks follow up. The difference in defocus 
curves shows a decrease of 0.05 logMAR at best focus (-0.35 ± 0.57 lines, p = 0.0009), 
with no change for intermediate vergence (-1.00D and -1.50D) and a mean gain of 2 
lines for near vergence (-2.00D and closer, p = 0.00400) at one year follow up. A slightly 
better distance vision was observed preoperatively, but the near and intermediate vision 
(at 2.00D//50 cm and 2.50D//40 cm) improved post-operatively.  
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Fig. 10. Change in corneal asphericity (Q value) at 3mm diameter, Strehl ratio (Strehl), Root mean square 
(RMS) of higher order aberrations (at 6mm diameter), corneal and ocular spherical aberrations (Corn SA 
and OC SA respectively, at 6mm diameter) preoperatively, and at one year follow up after treating with 
Hybrid bi-aspheric micro-monovision ablation profile for presbyopic corneal treatments. Here M and Y 
represent months and years respectively. One year post-operatively, the Strehl ratio reduced by ~-
4±14%, the corneal and ocular spherical aberrations (at 6mm diameter) decreased by -0.38±0.33µm and 
-0.28±0.35µm respectively, with an increase in RMS higher order aberrations (at 6mm diameter) by 
0.15±0.24µm. All these metrics indicated good stability from 3 months onwards.  
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Fig. 11. Binocular defocus curves from uncorrected vision asymmetrically to longer (+1.5D) and shorter 
vergences (-4.0D), assessed preoperatively and at one year follow up after treating with Hybrid bi-
aspheric micro-monovision ablation profile for presbyopic corneal treatments. The error bars represent 
the upper and lower 95% confidence limits of the mean of measurements, preoperatively. The upper and 
lower envelop represents respectively, the maximum and minimum values of the confidence limits  of 
postoperative measurements (irrespective of the follow up time) with respect to vergence. Here W, M and 
Y represent weeks, months and years respectively. 
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Fig. 12. Change in Defocus curves with respect to vergence, assessed preoperatively and at last follow 
up after treating with Hybrid bi-aspheric micro-monovision ablation profile for presbyopic corneal 
treatments. At one year follow up, a loss of half a logMAR was observed at best focus for distance, with 
no change for intermediate vergence (-1.25D) and a mean gain of 2 lines for near vergence (-3D).  
 
 
RETREATMENTS 
 
Secondary treatment was performed in 12 eyes (11 patients: 19% from the 64 eyes; 7 
eyes in Myopic group (of 6 patients) and 5 eyes in Hyperopic group (of 5 patients) to 
improve distance (9 eyes) or near (3 eyes) outcomes. The secondary treatments were 
performed using a non-wavefront guided aspheric treatment to tune distance refraction 
to the desired value. All retreatments were performed at least 6-months follow-up after 
the initial treatment.  Figure 13 presents the pre-operative CDVA (pre-PresbyMAX) and 
the post-operative UDVA (pre and post-retreatment) and spherical equivalent refraction 
in the eyes that underwent a secondary treatment. At one year follow up from the initial 
treatment (i.e. up to 6-months post-retreatment), 83% of myopic patients and 100% of 
hyperopic patients undergoing secondary treatment achieved a 20/20 or better 
binocular UDVA. Compared to the outcomes at 6 months follow up pre-retreatment, 
significant improvements were observed post-retreatment (only 20% myopic and 60% 
hyperopic patients achieved 20/20 or better binocular UDVA six months post-operatively 
after the initial treatment). Binocular UIVA and UNVA remained relatively stable in these 
eyes through the post-operative follow ups. 
Two eyes (3% from the 64 eyes) underwent a partial presby reversal treatment to 
reduce the effects of the primary treatment, due to the patient’s perceived intolerance 
(mainly loss of CDVA) to the induced multifocality. The details about the reversal of this 
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and the dominant eye imparting an improvement in Quality of Vision scores. Most of the 
outcome measures showed significant improvement compared to the pre-op status. The 
improvement in corrected and uncorrected distance and near visual acuity was 
significant post operatively. Improvements in refraction and visual acuity were also seen 
in patients undergoing secondary treatments. In addition, analyzing the Near Activity 
Visual Questionnaire responses revealed an improvement in all the topics and the 
Rasch scores indicated improvements from little (pre-op) to high (post-op) satisfaction.  
Although, it would be interesting to know the profile of the defocus curves monocularly 
for the presbyopic eyes, this was not possible due to the retrospective nature of this 
study. However, the defocus curves with both eyes corrected for distance, i.e. 
eliminating the effect of the micro-monovision component, revealed a loss of half a 
Snellen line at the best focus for distance, but a gain of 2 lines at the near vergence. 
Monocularly, it would be expected that the defocus curves would be shallower, with 
separation between the dominant and non-dominant eye. The metric area under the 
defocus curves demonstrates a slight drop at distance vision postoperatively, but not a 
gain at near or intermediate vision. This could be due to the curves crossing at near (-
2.00D to -4.00D) and intermediate (-0.50D to -2.00D) vision boundary; and missing data 
points in this range.   
  Corneal topography and aberrometery revealed a decrease in corneal and ocular 
spherical aberrations, associated with an increase in the RMS higher order aberrations. 
Furthermore, Quality of Vision responses revealed minor decline in terms of blurred 
vision, haloes and double vision post operatively compared to the patient responses 
preoperatively (using correction glasses). Stability inthe Near Activity Visual 
Questionnaire rating and refraction was reached after 3 months and 6 weeks 
postoperatively. The presented clinical outcomes are based on 1 year of clinical follow 
up, which is considered adequate in refractive surgery. However, presbyopia increases 
with age. Therefore, longer follow up could shed light on the durability of performance 
during further degradation of accommodation. As a recommendation from the 
manufacturer of the laser system, patients were required to have pupil diameters 
smaller than 3.0mm in photopic (for effectively using the central near disk of the profile) 
and larger than 4.5mm in mesopic light conditions (for getting enough light in the 
distance focus using the pericentral distance annulus of the profile; however, pupil 
diameters were obtained from the topography, and eyes with pupil diameter smaller 
than 3.0 mm in photopic conditions are currently included for surgery by the clinic.  
Many clinical studies have evaluated various surgical techniques to treat 
presbyopia; however the current developments throughout the corneal presbyopic 
correction spectrum indicate a converging trend towards hybrid techniques. These 
hybrid modifications include: SupracorTM (TECHNOLAS Perfect Vision GmbH), 
PresbyMAX (reduced multifocality in distance eye combined with full multifocality and 
monovision in the near eye), Intracor (full correction in distance eye combined with 
Intracor multifocality and monovision in the near eye), KAMRATM (AcuFocus, Inc.) (full 
correction in distance eye combined with pinhole based extended depth-of-focus and 
monovision in the near eye), PresbyondTM (Carl Zeiss Meditec AG) laser blended vision 
(moderate multifocality in both eyes combined with monovision in the near eye) and 
refractive corneal inlays (e.g. raindropTM from ReVision Optics, USA).   
A brief summary and comparison of the clinical studies with different methods to 
treat presbyopia is presented in Table 1, although intermediate visual acuity is not 
21 
 
included due to the unavailability of this metric in most studies. However, Seyeddain et 
al.26 reported in their cohort, 71.9% treatments achieving 20/20 or better UIVA 
compared to the 63% reported in our cohort. 
 
Table 1. A comparison of clinical outcomes using different techniques for laser presbyopia corrections1. 
Study n Follow 
Up 
Group/Sub group UDVA 20/20 or 
better 
UNVA J2 or better CDVA Loss 2 or 
more lines 
Ret  Rev 
Presby LASIK 
Alio et 
al8 
50 6 M Presb 64% 72% (20/40 or 
better)  
14%  12% - 
Luger 
et at.11 
66 1 Y Hyp and myo 
with/without astig 
48% 94% 3% - - 
Luger 
et al20 
48 3 M Hyp and myo 
with/without astig 
25% 50% - 0% 0% 
Iribarne 
et al.21 
50 6 M Hyp and myo 
with/without astig 
41% 91% 5% - - 
Bauda 
et al22 
716 6 M Myo 43% 98% 26% 19% 1% 
Hyp 45% 90% 25% (Overall) (Over
all) 
Monovision 
Wright 
et al.3 
42 7 M (3-
15) 
Myo presb treated 
with PRK induced 
monovision 
76.2% 100% (20/30 or 
better) 
- 26.2% - 
32 11 M 
(3-17) 
Emm treated with 
PRK 
62.5% 25% (20/30 or 
better) 
- 37.5% - 
Alarcon 
et al28 
50 3 M  90% 90% (J1 or better) - 12% - 
Conductive keratoplasty 
Stahl.29 10 1 Y 1 Y follow up 89% (20/20 and J1) 89% - 0% 
(overall) 
0% 
(over
all) 
9 3 Y 3 Y follow up 22% (20/20 and J1) 33% - 
Supracor 
Ryan 
et al.30 
46 6 M Hyp 48% 73.9% (J5 or 
better) 
4% 21.7% - 
Intracor 
Holzer 
et al.31 
25 3 M  48% 8% (20/20 or 
better) 
8% - - 
Intracorneal Inlay 
Yilmaz 
et al.32 
22 4 Y Emm or post LASIK 
presb 
73% 96% (J3 or better) 5% 22.7% 
(Cataract 
extraction) 
18.2% 
Seyedd
ain et 
al.33 
32 2 Y Emm presb  74 % 65.6% (J1 or 
better) 
6% 6.3% 0% 
Tomita 
et al.34 
223 6 M Presb patients with 
previous LASIK 
100% 77% 0% - - 
Multifocal IOL 
McAlin
din et 
al.2 
44 3 M - 68.2% - 0% 13.6% 0% 
Biaspheric cornea modulation 
Uthoff 
et al.35 
20 6 M Emm 80% (0.1 logMar) 40% (0.1 logRad) 10% 6.6% to 
10% (may 
require 
overall) 
 
20 6 M Hyp 100% (0.1 logMar) 30% (0.1 logRad) 10%  
20 6 M Myo 70% (0.1 logMar) 60% (0.1 logRad) 20%  
Presented study 
Current 64 1 Y  93% 90% 7% 19% 3% 
1 Here M is months, Y is year, Myo is myopia, Hyp is hyperopia, Emm is emetropia, presb is presbyopia, astig is astigmatism, n is 
number of eyes, CDVA is corrected distance visual acuity, UDVA is uncorrected distance visual acuity, UNVA is uncorrected near 
visual acuity, Ret is retreatments and Rev is reversals. 
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Methods depending only on the depth of focus might face difficulty to create more 
than 1.5D of near vision independence. In contrast, with the models based on multifocal 
ablations one can gain a higher near vision independence. Since, presbyopia increases 
with age, a wide range of near vision shall be an asset in such cases. In addition, the 
difference in the depth of focus between the near and far eye provides the patient with a 
wider binocular range of focus for an enhanced intermediate vision.  
The depth of focus acts as a useful marker, however, some studies consider 
acuity at a typical near vision distances as a more suitable metric that is closely related 
to patients’ real expectations and concerns27. Our analysis and results indicate 
significant success in presbyopic treatments using the hybrid bi-aspheric micro-
monovision ablation profiles. We evaluated the subjective perception of patients for 
distant (Quality of Vision) and near visual quality (Near Activity Visual Questionnaire 
scores) and found significant improvements in the Near Activity Visual Questionnaire 
scores with improved uncorrected and corrected near and distance visual acuity and 
contrast sensitivity. Presbyopic treatment using a hybrid bi-aspheric micro-monovision 
ablation profile is safe and efficacious. The post-operative outcomes indicate 
improvements in binocular vision at far, intermediate and near distances with improved 
contrast sensitivity. A 19% retreatment rate should be considered to increase 
satisfaction levels, besides a 3% reversal rate. 
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